SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-020935
Filing Date
2008-04-01
Accepted
2008-04-01 11:35:49
Documents
1
Period of Report
2008-03-28

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION b69439cm.html 4  
1 MAIN DOCUMENT DESCRIPTION b69439cm.xml 4 20413
  Complete submission text file 0001209191-08-020935.txt   22361
Mailing Address 122 WEST 42ND STREET SUITE 2606 NEW YORK NY 10168
Business Address 122 WEST 42ND STREET SUITE 2606 NEW YORK NY 10168 212-682-3096
Lev Pharmaceuticals Inc (Issuer) CIK: 0001144062 (see all company filings)

IRS No.: 880211496 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 535 BOYLSTON ST. SUITE 401 BOSTON MA 02116
Business Address 617-375-3000
Madison Christopher B (Reporting) CIK: 0001354644 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-32947 | Film No.: 08727928